Mathew Putzi, MD
Anatomic Pathology & Clinical Pathology · Austin, TXNPI 1538328935
Payments from drug & device makers
Across 59 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$260
- Johnson & Johnson$131
- Astellas Pharma US Inc$74
- Blue Earth Diagnostics$69
- Dendreon Pharmaceuticals LLC$68
- Myriad Genetic Laboratories, Inc.$68
- plus $411 from 15 others
What the payments were for
- Food & beverage$1,081100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $260 |
| Johnson & Johnson | 8 | $131 |
| Astellas Pharma US Inc | 4 | $74 |
| Blue Earth Diagnostics | 3 | $69 |
| Dendreon Pharmaceuticals LLC | 3 | $68 |
| Myriad Genetic Laboratories, Inc. | 5 | $68 |
| Myovant Sciences Inc. | 3 | $58 |
| Teleflex LLC | 3 | $46 |
| AstraZeneca | 2 | $40 |
| Foundation Medicine, Inc. | 1 | $38 |
| Endo Pharmaceuticals Inc. | 3 | $37 |
| Bayer | 2 | $34 |
| Merck | 1 | $23 |
| 180 Medical, Inc. | 1 | $22 |
| Clarus Therapeutics Inc. | 1 | $21 |
| Mission Pharmacal Company | 1 | $18 |
| Endo USA, Inc. | 1 | $18 |
| Progenics Pharmaceuticals, Inc. | 1 | $16 |
| Coloplast | 1 | $14 |
| Urovant Sciences Inc | 1 | $13 |
| Neotract Inc. | 1 | $12 |
How this compares
$1,081 in reported general payments places this provider in the 85th percentile of 736 anatomic pathology & clinical pathology providers in Texas.
See all anatomic pathology & clinical pathology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Austin
- Paulette Mhawech FaucegliaAustin$112K
- Mohamed SalamaAustin$15K
- Samantha NgamsuntikulSan Antonio$3.2M
- Eric SalazarHouston$1.2M
- Christopher BibbBryan$1.1M
- Rachel-Louise BeddardSan Antonio$809K
- Aamir EhsanSan Antonio$601K
- Rabia ShafiHouston$519K
- Robert BradyFort Sam Houston$479K
- Hesham AminHouston$429K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.